Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate–activated Citrate Synthase

Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, accounting for 50% of all heart failure patients, and is associated with significant mortality. Sodium–glucose cotransporter subtype inhibitor (SGLT2i) is recommended in the AHA and ESC guidelines for the treatment of HFpEF,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinxin, Wang, Ning, Fu, Peng, An, Yanliang, Sun, Fangfang, Wang, Chengdong, Han, Xiao, Zhang, Yunlong, Yu, Xiaohong, Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635406/
https://www.ncbi.nlm.nih.gov/pubmed/37643027
http://dx.doi.org/10.1097/FJC.0000000000001474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635406/
https://www.ncbi.nlm.nih.gov/pubmed/37643027
http://dx.doi.org/10.1097/FJC.0000000000001474

Ejemplares similares